Overview

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Status:
Recruiting
Trial end date:
2027-09-30
Target enrollment:
Participant gender:
Summary
This study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-2005 for Intravesical perfusion in patients with high-risk non-muscle invasive bladder cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.